Understanding Corticosteroid Injection Therapy

Musculoskeletal Conditions

Intra-articular (into the joint) corticosteroid injections are among the most common applications. Conditions that respond well include osteoarthritis, rheumatoid arthritis, gout flares, adhesive capsulitis (frozen shoulder), and bursitis. For knee osteoarthritis, guidelines from the American College of Rheumatology conditionally recommend intra-articular corticosteroids for patients who have had an inadequate response to oral or topical NSAIDs.

Periarticular injections target structures around joints, such as tendons (tendinitis), bursae (bursitis), and ligaments. Common sites include the subacromial bursa for shoulder impingement, the lateral epicondyle for tennis elbow, and the greater trochanteric bursa for hip bursitis. These injections often provide weeks to months of relief, allowing patients to participate in physical therapy and rehabilitation.

Spinal Conditions

Epidural steroid injections are widely used for spinal pain related to disc herniation, spinal stenosis, and radiculopathy. The corticosteroid is injected into the epidural space surrounding the spinal cord and nerve roots, where it reduces inflammation and swelling that compresses neural structures. Evidence supports their use as part of a multimodal approach to spine care, particularly for patients with acute radicular symptoms. These procedures are performed under fluoroscopic or ultrasound guidance for precision and safety.

Soft Tissue and Dermatological Uses

Intralesional corticosteroid injection is a mainstay treatment for keloid and hypertrophic scars, alopecia areata, and severe cystic acne. Small amounts of triamcinolone acetonide or methylprednisolone are injected directly into the lesion, reducing collagen overproduction in scars and suppressing immune-mediated hair follicle damage in alopecia. For skin conditions, this targeted approach avoids the metabolic effects of systemic corticosteroid therapy.

Systemic Inflammatory Conditions

While local injection is preferred when possible, intramuscular depot injections are sometimes used for systemic inflammatory conditions when oral therapy is impractical. Conditions include severe allergic reactions, acute asthma exacerbations, and flares of systemic lupus erythematosus. The depot formulation provides sustained systemic anti-inflammatory activity over one to three weeks.

Administration and Technique

Proper injection technique is critical for both efficacy and safety. Key principles include aseptic preparation of the injection site, accurate needle placement (increasingly guided by ultrasound or fluoroscopy), appropriate selection of needle gauge and length for the target tissue, and use of local anesthetic as a diluent for patient comfort.

Many practitioners combine the corticosteroid with a local anesthetic such as lidocaine. This provides immediate pain relief (confirming accurate needle placement) while the corticosteroid takes effect over the following days. The anesthetic component can also serve a diagnostic purpose: if the patient experiences significant immediate relief, it confirms that the injected structure was indeed the pain generator.

Safety Considerations and Side Effects

While generally safe when administered by trained practitioners, corticosteroid injections carry specific risks that patients should understand:

• Post-injection flare: Temporary worsening of pain and swelling in the 24-48 hours after injection, occurring in approximately 2-5% of patients. This is self-limiting and managed with ice and rest.
• Tissue atrophy: Repeated injections at the same site can cause thinning of the skin, subcutaneous tissue, or tendon. This is why most guidelines recommend limiting injections to 3-4 per year per joint.
• Infection: Though rare when proper aseptic technique is used (estimated at 1 in 10,000 to 1 in 50,000), septic arthritis following intra-articular injection is a serious complication requiring immediate treatment.
• Blood sugar elevation: Diabetic patients should be aware that corticosteroid injections can temporarily raise blood glucose levels for days to weeks. Close monitoring and potential temporary adjustment of diabetes medications may be needed.
• Systemic effects: Large or frequent doses can produce systemic corticosteroid effects including mood changes, insomnia, and transient facial flushing.

What to Expect After an Injection

Patients should rest the treated area for 24-48 hours following injection. The local anesthetic typically provides immediate relief that wears off within hours. The corticosteroid effect usually begins within 2-7 days, with peak benefit at 1-2 weeks. Duration of relief varies widely by condition and individual, ranging from weeks to months.

Physical therapy and exercise should typically be resumed gradually after the acute post-injection period. Many clinicians view the injection as a window of opportunity: the reduced pain and inflammation allow the patient to engage more effectively in rehabilitation exercises that address the underlying biomechanical or structural issues contributing to their condition.

Emerging Alternatives and Complementary Approaches

While corticosteroid injections remain a cornerstone of anti-inflammatory treatment, the field continues to evolve. Platelet-rich plasma (PRP) injections, hyaluronic acid viscosupplementation, and regenerative medicine approaches are being studied as alternatives or complements to traditional corticosteroid therapy. Current evidence is mixed, and guidelines vary by condition. For patients seeking to explore options beyond corticosteroids, particularly for chronic conditions requiring repeated treatment, discuss these alternatives with your treating physician. Additional resources on pain management strategies and related topics like fatigue in chronic conditions are available throughout our site.